Asset Details
Do you wish to reserve the book?
Characterization of molecular and structural determinants of selective estrogen receptor downregulators
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Characterization of molecular and structural determinants of selective estrogen receptor downregulators
Do you wish to request the book?
Characterization of molecular and structural determinants of selective estrogen receptor downregulators
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Characterization of molecular and structural determinants of selective estrogen receptor downregulators
2007
Overview
Antiestrogens used for breast cancer therapy can be categorized into two classes that differ in their effect on estrogen receptor (ER) alpha stability. The selective estrogen receptor modulators (SERMs) stabilize ER alpha and the selective estrogen receptor downregulators (SERDs) cause a decrease in cellular ER alpha levels. A clinically relevant antiestrogen, GW7604, appears to work through a SERD-like mechanism, despite sharing the same molecular scaffold as 4-hydroxytamoxifen, a SERM. In order to investigate potential structural features of GW7604 responsible for SERD activity, GW7604 and two analogs were synthesized using a new, improved synthetic route and tested for their effects on ER alpha function and cell proliferation. The two analogs, which have an acrylamide or a methyl vinyl ketone replacing the acrylic acid group of GW7604, display lower binding affinity for ER alpha than GW7604, but show similar antagonism of estradiol-induced activation of ER alpha-mediated transcription as GW7604 and inhibit estradiol-induced proliferation of the MCF-7 cell line with a similar potency as GW7604. Unlike GW7604, neither analog has a significant effect on cellular ER alpha levels, suggesting that the carboxylate is a key determinant in GW7604 action and, for the first time, showing that this group is responsible for inducing ER alpha degradation in breast cancer cells.
Publisher
Springer,Springer Nature B.V
Subject
/ Biological and medical sciences
/ Breast Neoplasms - drug therapy
/ Cell Proliferation - drug effects
/ Estrogen Receptor alpha - antagonists & inhibitors
/ Estrogen Receptor Modulators - chemistry
/ Estrogen Receptor Modulators - pharmacology
/ Gynecology. Andrology. Obstetrics
/ Humans
/ Selective estrogen receptor modulators
/ Tumors
We currently cannot retrieve any items related to this title. Kindly check back at a later time.